ReviewHormones (Athens, Greece)2021

Endocrine consequences of treatment with the new androgen receptor axis-targeted agents for advanced prostate cancer.

Nikolaos Pyrgidis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.